# A Study of LY2979165 in Healthy Subjects

> **NCT01383967** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 102 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** LY2979165
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01383967
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2012-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01383967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01383967, "A Study of LY2979165 in Healthy Subjects". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01383967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*